Form 4: Orthofix Director Michael Finegan Acquires 21,368 Shares of Common Stock

Director Michael Finegan acquired 21,368 shares of Orthofix Medical Inc. common stock on June 18, 2024, and holds 29,718 deferred stock units.

Summary

• On June 18, 2024, Michael Finegan, a director of Orthofix Medical Inc., acquired 21,368 shares of common stock at a price of $12.87 per share.
• The acquisition was made through an award of deferred stock units that vest in full on the first anniversary of the grant date, contingent upon the reporting person's continued service.
• Following the transaction, Finegan beneficially owns 29,718 deferred stock units.
• Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally seen as a positive sign, but the filing itself is a routine disclosure.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's increased stake in the company, which is generally viewed positively by investors.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholders, as it signals confidence in the company's prospects.

Key Dates